论文部分内容阅读
目的 :观察对于支气管哮喘患者实施多索茶碱和氨茶碱治疗的效果,并比较探究疗效。方法 :选取在2013年4月-2014年3月期间在我院治疗的68例支气管哮喘患者作为研究对象,同时于患者享有知情权并获得同意的情况下展开随机分组,分组的结果为研究组和参照组分别34例。给予两组不同形式的治疗方案,即将多索茶碱应用于研究组患者的治疗中,将氨茶碱应用于治疗参照组患者中,统计并比较临床治疗总有效率以及不良反应现象的发生率。结果 :经过实施治疗总体有效率的统计,研究组的总体有效率为94.12%,相对于参照组获得的70.59%而言,具有显著优势(P<0.05);同时对比不良反应发生情况,研究组的不良反应发生率为11.76%,低于参照组的26.46%,差异性明显(P<0.05)。结论 :针对支气管哮喘患者实施多索茶碱治疗效果更为理想,在提升总有效率的同时,也相对具备安全性。因此,此种治疗举措具有广泛应用于实践治疗的价值。
Objective: To observe the effect of doxofylline and aminophylline in patients with bronchial asthma and to explore the curative effect. METHODS: Sixty-eight patients with bronchial asthma who were treated in our hospital from April 2013 to March 2014 were selected as study subjects and randomized patients were given the right to information and consent, and the results were divided into groups And reference group were 34 cases. Two groups of different forms of treatment were given. Doxofylline was used to treat patients in the study group. Aminophylline was used to treat patients in the reference group. The total effective rate of clinical treatment and the incidence of adverse reactions were compared . Results: The total effective rate of the study group was 94.12%, which was significantly higher than that of the reference group (70.59%) (P <0.05). After comparing the incidence of adverse reactions, the study group The incidence of adverse reactions was 11.76%, which was significantly lower than that of the reference group (26.46%) (P <0.05). Conclusion: The effect of doxofylline treatment for patients with bronchial asthma is more ideal, while improving the total efficiency, but also relatively safe. Therefore, such treatment measures have the value of being widely used in the practice of treatment.